knowledge -WSS

knowledge

author：knowledge 2025-09-27 10:02:40 - browse：317

On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Xenotransplantation trials will require adjusting expectations, experts say

hotspot

leisure time

WSS

Biden administration plans revamp of organ transplant system

Inside the rise of 'mukbang' eating videos

Can medical device makers keep up in the race to treat obesity?

Stories you might have missed in 2023: health, science, medicine

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

FDA early review: GLP

hotspot

knowledge

focus

Hepatitis C has a cure — but many Americans still lack access to it

Mom launches Girl Scout troop for LGBTQ youth in Texas

At least 13 dead in Texas as scorching temps continue

Biogen nominates mother of director’s child to replace him on board

The high cost of giving birth even with insurance

American taxpayers paid $1.8 trillion in health care costs in 2022

Psychedelics group wrestles with new pharma identity

FDA early review: GLP

New air purifier tech could be key to improving indoor air quality

Stories you might have missed in 2023: health, science, medicine

focus

Reanimated hearts work just as well for transplants, study finds

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

STAT Virtual Event: JPM Recap, Live!

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

FDA approves first new drug developed for postpartum depression

FDA approves first new drug developed for postpartum depression

focus

hotspot

leisure time

focus